Zydus's ''fingerprint match'' Humira version debuts in India

 
• By Anju Ghangurde

Zydus Cadila has launched the first ever biosimilar version of AbbVie's blockbuster biologic, Humira (adalimumab), in India at a fraction of the innovator product price.

More from Alimentary/Metabolic

More from Therapy Areas